Back to results
CompletedPhase 2

Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease

NCT02655315

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Medizinische Universitat Innsbruck

Innsbruck, Austria

+24 additional locations

View on ClinicalTrials.gov
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease — TrialFind